688016 logo

Shanghai MicroPort Endovascular MedTech Co., Ltd. Stock Price

SHSE:688016 Community·CN¥12.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author

688016 Share Price Performance

CN¥104.64
-2.27 (-2.12%)
CN¥104.64
-2.27 (-2.12%)
Price CN¥104.64

688016 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Flawless balance sheet with high growth potential.

2 Risks
3 Rewards

Shanghai MicroPort Endovascular MedTech Co., Ltd. Key Details

CN¥1.1b

Revenue

CN¥367.7m

Cost of Revenue

CN¥765.8m

Gross Profit

CN¥352.6m

Other Expenses

CN¥413.2m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 30, 2025
3.41
67.56%
36.45%
0%
View Full Analysis

About 688016

Founded
2012
Employees
832
CEO
Qing Zhu
WebsiteView website
www.endovastec.com

Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, and sale of aortic and peripheral vascular medical devices in China and internationally. The company’s products include branched aortic stent graft system, thoracic stent graft system, abdominal aortic stent graft and delivery system, bifurcated stent graft system, and other stent graft system in surgical operation, as well as accessories, such as balloon inflation catheter. Shanghai MicroPort Endovascular MedTech Co., Ltd. was incorporated in 2012 and is based in Shanghai, the People’s Republic of China.

Recent 688016 News & Updates

Recent updates

No updates